Distinct Accumbens Shell Output Pathways Promote Versus Prevent Relapse to Alcohol Seeking
Overview
Authors
Affiliations
Contexts exert bi-directional control over relapse to drug seeking. Contexts associated with drug self-administration promote relapse, whereas contexts associated with the absence of self-administration protect against relapse. The nucleus accumbens shell (AcbSh) is a key brain region determining these roles of context. However, the specific cell types, and projections, by which AcbSh serves these dual roles are unknown. Here, we show that contextual control over relapse and abstinence is embedded within distinct output circuits of dopamine 1 receptor (Drd1) expressing AcbSh neurons. We report anatomical and functional segregation of Drd1 AcbSh output pathways during context-induced reinstatement and extinction of alcohol seeking. The AcbSh→ventral tegmental area (VTA) pathway promotes relapse via projections to VTA Gad1 neurons. The AcbSh→lateral hypothalamus (LH) pathway promotes extinction via projections to LH Gad1 neurons. Targeting these opposing AcbSh circuit contributions may reduce propensity to relapse to, and promote abstinence from, drug use.
GluN2B-mediated regulation of silent synapses for receptor specification and addiction memory.
Kim H, Lee S, Kim G, Sung K, Yoo T, Pyo J Exp Mol Med. 2025; 57(2):436-449.
PMID: 39930130 PMC: 11873126. DOI: 10.1038/s12276-025-01399-z.
Negishi K, Navarro V, Montes L, Arzate L, Guerra Ruiz J, Sotelo D bioRxiv. 2025; .
PMID: 39868339 PMC: 11761604. DOI: 10.1101/2025.01.18.633747.
Dissociable control of motivation and reinforcement by distinct ventral striatal dopamine receptors.
Enriquez-Traba J, Arenivar M, Yarur-Castillo H, Noh C, Flores R, Weil T Nat Neurosci. 2024; 28(1):105-121.
PMID: 39653808 DOI: 10.1038/s41593-024-01819-9.
The nucleus accumbens shell: a neural hub at the interface of homeostatic and hedonic feeding.
Marinescu A, Labouesse M Front Neurosci. 2024; 18:1437210.
PMID: 39139500 PMC: 11319282. DOI: 10.3389/fnins.2024.1437210.
Costa P, Everett N, Turner A, Umpierrez L, Baracz S, Cornish J Psychopharmacology (Berl). 2024; 241(8):1539-1554.
PMID: 38705893 PMC: 11269403. DOI: 10.1007/s00213-024-06580-2.